Security key
H0036K147
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Shares, par value CHF 0.08 per share
- Shares outstanding
- 128,459,465
- Total 13F shares
- 56,494,277
- Share change
- +847,366
- Total reported value
- $112,422,732
- Put/Call ratio
- 185%
- Price per share
- $1.99
- Number of holders
- 82
- Value change
- -$3,041,138
- Number of buys
- 45
- Number of sells
- 26
Report period
Q4 2024
Institutions
82
Top holders
10
ADCT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
ADC Therapeutics SA SEC filings
ADC Therapeutics SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP H0036K147
Recent filing periods:
Ownership snapshot
Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Redmile Group, LLC
13D/G signal
—
Evidence rows
50
Latest as of
30 Sep 2024
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
Company
|
12%
|
$49,358,034
15,669,217 shares
|
— | 30 Sep 2024 |
| Prosight Management, LP |
13F
Company
|
7.5%
|
$30,354,147
9,636,237 shares
|
— | 30 Sep 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
3.5%
|
$14,281,473
4,533,801 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
3.4%
|
$13,857,274
4,399,134 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
2.4%
|
$9,578,500
3,040,794 shares
|
— | 30 Sep 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
1.9%
|
$7,868,511
2,497,940 shares
|
— | 30 Sep 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$5,654,502
1,795,080 shares
|
— | 30 Sep 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
1.3%
|
$5,319,071
1,688,594 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
82
Shares
56,494,277
Rows loaded
82
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
76
Q4 2024 holders
82
Holder diff
6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend